Meta-Analysis Evaluating the Incidence of Bleeding Events With Intravenous Defibrotide Treatment Outside the Veno-Occlusive Disease/Sinusoidal Obstruction Syndrome Setting (With Jazz Pharmaceuticals)

Indirect Treatment Comparison of Valbenazine and Deutetrabenazine (with Neurocrine Biosciences)

Comparative effectiveness review of Valbenazine and Tetrabenazine (with Neurocrine Biosciences)

Systematic review and pooled meta-analysis for Defibrotide (with Jazz Pharmaceuticals)

Study on need for treatment with biologics for early Crohn's disease patients (with Abbvie)

Systematic Review on Hepatitis C Demonstrating Value of Treatment (With Abbvie).

Meta-Analysis and Economic Model for a Johnson & Johnson Device (October 2015, PDF of the Paper)

Strategy Overview on Breakthrough Therapy Designations in Nature Biotechnology

What's Fueling the Biotech Engine-2012 to 2013: Strategy Perspective on More than Hundred Branded Biotech Products (Nature Biotechnology | Top 5 Most Downloaded Articles)

Special Report: Top Strategy Mishaps of 2011-2012, Lessons and Implications for 2013-2020 (February 2013)

What's Fueling the Biotech Engine-2011 to 2012: Strategy Perspective on More than Hundred Branded Biotech Products (December 2012, Nature Biotechnology)

Overview of Clinical, Business and Reimbursement Trends for Targeted Cancer Therapies in Nature Reviews (More Than 20,000 Downloads)

Emerging Role of Biomarkers for Success of Targeted Therapies : Invited Key Note Lecture at BIOVISION (Lyon, France)

Trends In Use of Health Economic Evidence For Developing Clinical Guidelines (2015)

Patient Reported Outcomes In Glaucoma A Systematic Review (2015)

Systematic Review of Epidemiology And Burden of Pancreatic Cancer (2015)

Systematic Review of Epidemiology And Burden of Cutaneous T-Cell Lymphoma (2015)

Overview And Importance of NUB Process For Market Access of In-Patient Drugs And Devices In Germany (2015)

Impact of 2014 Essential Health Benefit Benchmark Plans On Us Managed Care (2015)

Impact of New Changes Due To Affordable Care Act On Us Market Access (2015)

Comparative Effectiveness, Approval Rates And Pricing of Drugs With FDA's Breakthrough Therapy Designations (2015)

Comparison of Ultra Orphan And Cancer Drug Pricing In The US And The UK (2015)

Systematic Review of Cost Effectiveness of Ultra-Orphan Therapies: Lesson Learned From Published HTAs And Studies (Podium Presentation, 2015)

Cost Effectiveness Trends of High Budget Impact Drugs(Podium Presentation at ISPOR Annual Meeting in Washington DC)

Cancer Drug Access Trends and Role of Patient Assistance Programs (ACCC Annual Meeting)

CMS increases reimbursement for CAR-T therapies

Canada to drop United States and Switzerland from price referencing

Canada conditionally recommends Lutathera

5 commonly made mistakes for GVDs

Note: For Full List of Our 200+ Publications or for In-Person Replay of Events Email Us at

info@NovelHealthStrategies.com

NOVEL's Study on Oral Cancer Drugs Selected for Presentation at ASCO Annual Meeting: Relationships between food effects, patient adherence to treatment, and pharmacokinetics of oral anticancer drugs (June, 2014)

NOVEL Selected for Multiple Peer-Reviewed Podium and Poster Presentations at HTAi 2014, DC (June, 2014)

Fifteen Podium and Poster Presentations at ISPOR Montreal, Canada (June, 2014)

Ten Presentations at ISPOR EU Dublin, Ireland (November, 2013)

Podium and Poster Presentations at HTAi 2013 Annual Meeting in Seoul, Korea

Nineteen Presentations at 18th ISPOR Annual Meeting in New Orleans

Ten Poster/Podium Presentations at ISPOR Berlin, Germany (November, 2012)

Systematic Review of India Healthcare Reforms (Authors: Kumar S and Bela A)

Universal Coverage in India (Authors: Kumar S and Bela A)

100 Years of Healthcare Reforms in India (Book Draft by Bela A and Kumar S)